Literature DB >> 28864676

A predictive model to identify Parkinson disease from administrative claims data.

Susan Searles Nielsen1, Mark N Warden1, Alejandra Camacho-Soto1, Allison W Willis1, Brenton A Wright1, Brad A Racette2.   

Abstract

OBJECTIVE: To use administrative medical claims data to identify patients with incident Parkinson disease (PD) prior to diagnosis.
METHODS: Using a population-based case-control study of incident PD in 2009 among Medicare beneficiaries aged 66-90 years (89,790 cases, 118,095 controls) and the elastic net algorithm, we developed a cross-validated model for predicting PD using only demographic data and 2004-2009 Medicare claims data. We then compared this model to more basic models containing only demographic data and diagnosis codes for constipation, taste/smell disturbance, and REM sleep behavior disorder, using each model's receiver operator characteristic area under the curve (AUC).
RESULTS: We observed all established associations between PD and age, sex, race/ethnicity, tobacco smoking, and the above medical conditions. A model with those predictors had an AUC of only 0.670 (95% confidence interval [CI] 0.668-0.673). In contrast, the AUC for a predictive model with 536 diagnosis and procedure codes was 0.857 (95% CI 0.855-0.859). At the optimal cut point, sensitivity was 73.5% and specificity was 83.2%.
CONCLUSIONS: Using only demographic data and selected diagnosis and procedure codes readily available in administrative claims data, it is possible to identify individuals with a high probability of eventually being diagnosed with PD.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28864676      PMCID: PMC5631173          DOI: 10.1212/WNL.0000000000004536

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Bahi Takkouche; Francisco Caamaño-Isorna; Juan J Gestal-Otero
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

2.  Increased risk of Parkinson's disease after depression: a retrospective cohort study.

Authors:  A G Schuurman; M van den Akker; K T J L Ensinck; J F M Metsemakers; J A Knottnerus; A F G Leentjens; F Buntinx
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

3.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

Review 4.  The Parkinson Progression Marker Initiative (PPMI).

Authors: 
Journal:  Prog Neurobiol       Date:  2011-09-14       Impact factor: 10.885

5.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

6.  Gout and risk of Parkinson disease: a prospective study.

Authors:  Alvaro Alonso; Luis A García Rodríguez; Giancarlo Logroscino; Miguel A Hernán
Journal:  Neurology       Date:  2007-10-23       Impact factor: 9.910

7.  A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.

Authors:  C Warren Olanow; Christopher G Goetz; Jeffrey H Kordower; A Jon Stoessl; Vesna Sossi; Mitchell F Brin; Kathleen M Shannon; G Michael Nauert; Daniel P Perl; James Godbold; Thomas B Freeman
Journal:  Ann Neurol       Date:  2003-09       Impact factor: 10.422

8.  REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.

Authors:  J F Gagnon; M A Bédard; M L Fantini; D Petit; M Panisset; S Rompré; J Carrier; J Montplaisir
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

9.  Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Authors:  Anette Schrag; Laura Horsfall; Kate Walters; Alastair Noyce; Irene Petersen
Journal:  Lancet Neurol       Date:  2014-11-27       Impact factor: 44.182

Review 10.  The Concept of Prodromal Parkinson's Disease.

Authors:  Philipp Mahlknecht; Klaus Seppi; Werner Poewe
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more
  18 in total

1.  Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries.

Authors:  Alejandra Camacho-Soto; Anat Gross; Susan Searles Nielsen; Neelendu Dey; Brad A Racette
Journal:  Parkinsonism Relat Disord       Date:  2018-02-09       Impact factor: 4.891

2.  Artificial intelligence in sleep medicine: background and implications for clinicians.

Authors:  Cathy A Goldstein; Richard B Berry; David T Kent; David A Kristo; Azizi A Seixas; Susan Redline; M Brandon Westover
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

3.  Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study.

Authors:  Maya R Silver; Brad A Racette; Umber Dube; Irene M Faust; Susan Searles Nielsen
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

4.  Traumatic brain injury in the prodromal period of Parkinson's disease: A large epidemiological study using medicare data.

Authors:  Alejandra Camacho-Soto; Mark N Warden; Susan Searles Nielsen; Amber Salter; David L Brody; Heidi Prather; Brad A Racette
Journal:  Ann Neurol       Date:  2017-10-31       Impact factor: 10.422

5.  β2-adrenoreceptor medications and risk of Parkinson disease.

Authors:  Susan Searles Nielsen; Anat Gross; Alejandra Camacho-Soto; Allison W Willis; Brad A Racette
Journal:  Ann Neurol       Date:  2018-10-30       Impact factor: 10.422

6.  Fractures in the prodromal period of Parkinson disease.

Authors:  Alejandra Camacho-Soto; Anat Gross; Susan Searles Nielsen; Anna N Miller; Mark N Warden; Amber Salter; Brad A Racette
Journal:  Neurology       Date:  2020-04-28       Impact factor: 9.910

7.  Herpesvirus Infections and Risk of Parkinson's Disease.

Authors:  Alejandra Camacho-Soto; Irene Faust; Brad A Racette; David B Clifford; Harvey Checkoway; Susan Searles Nielsen
Journal:  Neurodegener Dis       Date:  2021-01-18       Impact factor: 2.977

8.  A Rapid Motor Task-Based Screening Tool for Parkinsonism in Community-Based Studies.

Authors:  Wendy W Dlamini; Searles Nielsen; Mwiza Ushe; Gill Nelson; Brad A Racette
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.086

9.  Use of medical care biases associations between Parkinson disease and other medical conditions.

Authors:  Anat Gross; Brad A Racette; Alejandra Camacho-Soto; Umber Dube; Susan Searles Nielsen
Journal:  Neurology       Date:  2018-05-09       Impact factor: 9.910

10.  Solvent exposed occupations and risk of Parkinson disease in Finland.

Authors:  Susan Searles Nielsen; Mark N Warden; Markku Sallmén; Markku Sainio; Sanni Uuksulainen; Harvey Checkoway; Christer Hublin; Brad A Racette
Journal:  Clin Park Relat Disord       Date:  2021-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.